A pharmaceutical royalty company that acquires interests in approved and late-stage biopharmaceutical products in exchange for upfront capital to drug developers and research institutions. Its portfolio generates revenue from sales of therapies across areas such as oncology, rare diseases, and immun...
No congressional trades have been disclosed for Royalty Pharma PLC Class A (RPRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.